These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 9437296)

  • 1. Use of statins. Sheffield tables have shortcomings.
    Betteridge J; Shepherd J; Thompson G
    BMJ; 1997 Dec; 315(7122):1619. PubMed ID: 9437296
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of statins. Standing Medical Advisory Committee should reconsider advice to use Sheffield risk table.
    Reynolds TM
    BMJ; 1997 Dec; 315(7122):1620. PubMed ID: 9437298
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of statins. But New Zealand tables are better.
    McLeod AJ; Armitage M
    BMJ; 1998 Aug; 317(7156):474. PubMed ID: 9758472
    [No Abstract]   [Full Text] [Related]  

  • 4. Statins and the prevention of coronary heart disease: striking a balance that is desirable, affordable, and achievable.
    Ritchie LD
    Br J Gen Pract; 2000 Sep; 50(458):693-5. PubMed ID: 11050781
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of statins. Other, cheaper and simpler, measures should be tried first.
    Sheridan P; Savege P; Silverman S
    BMJ; 1997 Dec; 315(7122):1616. PubMed ID: 9437287
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of statins. Evidence on effectiveness is stronger for statins than for other treatments.
    Wallis EJ; Ramsay LE; Yeo WW; Jackson PR; Pickin M; Haq IU
    BMJ; 1997 Dec; 315(7122):1618-9. PubMed ID: 9437295
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of statins. Health authorities must work with clinicians to target statins.
    Wakeman AP; Leach RH
    BMJ; 1997 Dec; 315(7122):1618. PubMed ID: 9437293
    [No Abstract]   [Full Text] [Related]  

  • 8. Statins and strokes--reducing the risk.
    Jackson G
    Int J Clin Pract; 1999; 53(3):159. PubMed ID: 10665124
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of statins. Results of different studies differed greatly.
    Mikhailidis DP; Winder AF
    BMJ; 1997 Dec; 315(7122):1617. PubMed ID: 9437291
    [No Abstract]   [Full Text] [Related]  

  • 10. Applying the Sheffield tables to data from general practice.
    Muir J; Fuller A; Lancaster T
    Br J Gen Pract; 1999 Mar; 49(440):217-8. PubMed ID: 10343427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The secondary prevention of coronary disease: ACE inhibitors, adrenergic beta-blockers and statins for everyone? The arguments con].
    Simões L; Guimarães J; Fontes JP
    Rev Port Cardiol; 2000 Jan; 19(1):107-13. PubMed ID: 10731796
    [No Abstract]   [Full Text] [Related]  

  • 12. Optimal age for starting lipid lowering treatment. Adjusted date do not justify a lower optimal age.
    Jackson PR; Wallis EJ; Ramsay LE
    BMJ; 2000 Sep; 321(7261):637-8. PubMed ID: 11023329
    [No Abstract]   [Full Text] [Related]  

  • 13. Statins for all?
    Hampton J
    Practitioner; 2002 Jun; 246(1635):373. PubMed ID: 12073695
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of statins. Trent Institute's Research Working Group has produced guidance for purchasers.
    Akehurst RL
    BMJ; 1997 Dec; 315(7122):1615-6. PubMed ID: 9437286
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of risk factors in primary prevention of cerebral ischemia].
    Auer J; Berent R
    Dtsch Med Wochenschr; 2001 Jul; 126(30):866. PubMed ID: 11512288
    [No Abstract]   [Full Text] [Related]  

  • 16. [For prevention of cardiovascular diseases: statins in old age?].
    MMW Fortschr Med; 2006 Sep; 148(38):16. PubMed ID: 17036955
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of statins. Cost effectiveness was studied in 4S study.
    Kjekshus J; Pedersen TR
    BMJ; 1997 Dec; 315(7122):1619-20. PubMed ID: 9437297
    [No Abstract]   [Full Text] [Related]  

  • 18. Predicting risk reduction of coronary disease in patients who are glucose intolerant: a comparison of treatment with fenofibrate and other lipid-modifying agents.
    Haffner SM; Ashraf T
    Manag Care Interface; 2000 Mar; 13(3):52-8. PubMed ID: 11066277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of statins in prevention of ischemic stroke].
    Pankiewicz J; Dembińska-Kieć A; Słowik A; Rudzińska M; Szczudlik A
    Przegl Lek; 2000; 57(7-8):406-10. PubMed ID: 11109315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein modifying effects of statins and fibrate in various age groups of coronary artery disease patients.
    Sharma R; Mahajan M; Singh B; Bal BS; Kant R
    J Indian Med Assoc; 2006 Sep; 104(9):492-4, 496, 498. PubMed ID: 17388006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.